Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/10481
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Modarai, M | - |
dc.contributor.author | Silva, E | - |
dc.contributor.author | Suter, A | - |
dc.contributor.author | Heinrich, M | - |
dc.contributor.author | Kortenkamp, A | - |
dc.date.accessioned | 2015-03-23T16:26:41Z | - |
dc.date.available | 2011 | - |
dc.date.available | 2015-03-23T16:26:41Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Evidence-based Complementary and Alternative Medicine, 2011: 213021, (2011) | en_US |
dc.identifier.issn | 1741-427X | - |
dc.identifier.issn | 1741-4288 | - |
dc.identifier.uri | http://www.hindawi.com/journals/ecam/2011/213021/ | - |
dc.identifier.uri | http://bura.brunel.ac.uk/handle/2438/10481 | - |
dc.description | Copyright © 2011 Maryam Modarai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | en_US |
dc.description.abstract | A major safety concern with the use of herbal medicinal products (HMP) is their interactions with conventional medicines, which are often mediated via the cytochrome P450 (CYP) system. Echinacea is a widely used over-the-counter HMP, with proven immunomodulatory properties. Its increasing use makes research into its safety an urgent concern. Previously, we showed that Echinacea extracts and its alkylamides (thought to be important for Echinacea's immunomodulatory activity) mildly inhibit the enzymatic activity of the main drug metabolising CYP isoforms, but to this date, there is insufficient work on its ability to alter CYP expression levels. We now report for the first time the effect of a commercial Echinacea extract (Echinaforce) and four Echinacea alkylamides on the transcription of the major drug metabolizing enzyme CYP3A4. HepG2 cells were exposed for 96 h to clinically relevant concentrations of Echinaforce (22, 11.6 and 1.16g mL-1) or the alkylamides (1.62 and 44 nM). CYP3A4 mRNA levels were quantified using real-time reverse transcription polymerase chain reaction (RT-PCR). Neither Echinaforce nor the alkylamides produced any significant changes in the steady-state CYP3A4 mRNA levels, under these conditions. In contrast, treatment with 50M rifampicin resulted in a 3.8-fold up-regulation over the vehicle control. We conclude that Echinaforce is unlikely to affect CYP3A4 transcriptional levels, even at concentrations which can inhibit the enzymatic activity of CYP3A4. Overall, our data provides further evidence for the lack of interactions between Echinacea and conventional drugs. | en_US |
dc.description.sponsorship | Bioforce, Switzerland and the Maplethorpe Trust (University of London). | en_US |
dc.language | eng | - |
dc.language.iso | en | en_US |
dc.publisher | Hindawi Publishing Corporation | en_US |
dc.subject | Herbal medicinal products | en_US |
dc.subject | Conventional medicines | en_US |
dc.subject | Cytochrome P450 (CYP) system | en_US |
dc.subject | Echinacea | en_US |
dc.subject | Drug metabolizing enzyme CYP3A4 | en_US |
dc.title | Safety of herbal medicinal products: Echinacea and selected alkylamides do not induce CYP3A4 mRNA expression | en_US |
dc.type | Article | en_US |
dc.identifier.doi | http://dx.doi.org/10.1093/ecam/nep174 | - |
dc.relation.isPartOf | Evidence-based Complementary and Alternative Medicine | - |
dc.relation.isPartOf | Evidence-based Complementary and Alternative Medicine | - |
pubs.volume | 2011 | - |
pubs.volume | 2011 | - |
pubs.organisational-data | /Brunel | - |
pubs.organisational-data | /Brunel/Brunel Staff by College/Department/Division | - |
pubs.organisational-data | /Brunel/Brunel Staff by College/Department/Division/College of Health and Life Sciences | - |
pubs.organisational-data | /Brunel/Brunel Staff by College/Department/Division/College of Health and Life Sciences/Dept of Life Sciences | - |
pubs.organisational-data | /Brunel/Brunel Staff by College/Department/Division/College of Health and Life Sciences/Dept of Life Sciences/Biological Sciences | - |
pubs.organisational-data | /Brunel/Brunel Staff by Institute/Theme | - |
pubs.organisational-data | /Brunel/Brunel Staff by Institute/Theme/Institute of Environmental, Health and Societies | - |
pubs.organisational-data | /Brunel/Brunel Staff by Institute/Theme/Institute of Environmental, Health and Societies/Health and Environment | - |
pubs.organisational-data | /Brunel/Specialist Centres | - |
pubs.organisational-data | /Brunel/Specialist Centres/IfE | - |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Fulltext.pdf | 638.89 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.